ACP-001 not checked

Ascendis Pharma A/S

FollowEvery change as it happens, and a Monday email
Stage
No active trials
 
Next date
None yet
 
Trials
0 active
4 in total
Targets
—
None known yet

What this is

How it works
How it works isn't classified yet
How it’s given
“Once weekly subcutaneous injection at a starting dose of 0.24 mg/kg/week”In the company’s words, NCT03305016 on ClinicalTrials.gov
Tested for
Growth Hormone Deficiency, Pediatric (2 trials), Endocrine System Diseases (2 trials), Hormone Deficiency (2 trials), Pituitary Diseases (2 trials), Adult Growth Hormone Deficiency, Growth Hormone Deficiency (GHD)
Main trialPhase 3
“A 26 week trial of TransCon hGH, a long-acting growth hormone product, administered once-a-week. Approximately 150 children (males and females) with growth hormone deficiency (GHD) will be included. All study participants will receive TransCon hGH. This is a global trial that will be conducted in, but not limited to, the United States, Canada, Australia, and New Zealand.”In the company’s words, NCT03305016 on ClinicalTrials.gov
Other names
TransCon hGH
Given with
Omnitrope (Sandoz)Other companies’ drugs in its trials

Other drugs for Growth Hormone Deficiency, Pediatric

All 5 drugs for Growth Hormone Deficiency, Pediatric

Coming up0

No dates coming up.

Changes0

Last 90 days

No changes yet. We started recording changes on 6 Nov 2026.

Trials4

TrialPhaseCompletesWhat it tests
Phase 3Completed 19 Mar 2019 A Safety, Tolerability and Efficacy Study of TransCon hGH in Children With Growth Hormone Deficiency
Phase 3Completed 21 Feb 2023 A Long-Term Trial Investigating Safety and Efficacy of TransCon hGH in Children With Growth Hormone Deficiency Who Have Completed a Prior TransCon hGH Clinical Trial
Phase 2Completed May 2011 A Safety, Pharmacokinetic and Pharmacodynamic Study of ACP-001 (TransCon hGH) in Adults With Growth Hormone Deficiency
Phase 2Completed Jul 2015 Safety, PK/PD (Pharmacokinetics/Pharmacodynamics) and Efficacy of ACP-001 Weekly Versus Daily hGH in Children With Growth Hormone Deficiency (GHD)
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026

Follow ACP-001

Following is part of Solo: you see every change to ACP-001 the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in